Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Opioid-Induced Cognitive Side Effects
NCT02226601Unknown
- Sponsor
- University of Arizona
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cognitive dysfunction comparing Aprepitant with Placebo (2 arms). Primary endpoint: Cognitive function. Status: unknown.
02
Drugs
aprepitant
03
Conditions
cognitive dysfunction
Beyond the preview
Go deeper on NCT02226601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226601.